This study corroborates earlier research, showing that key metabolic markers such as ALT, LDL, and HbA1C are strong positive predictors of NAFLD, emphasizing the importance of monitoring these factors in routine clinical practice [12,13,17]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.